Clinical & translational oncology

• 

  Año 2026, Vol. 28, Número 3

  • REVIEW ARTICLE

    • Applications of single-cell transcriptomics: updated insights in endometrial cancer

      Xiao Shuyue, Li Huixin, Liu Jianyao, Xu Hanzi, Gong Zhen, Zhong Shanliang, Xie Xinyi

      • Resumen

      págs. 729-745

      

    • Management of ocular toxicity in patients with gynecologic cancer receiving novel antibody–drug conjugates: a narrative review

      Giuseppa Scandurra, Filippo Marano, Vittorio Gebbia, María del Rosario Valero Muñoz, Daniela Sambataro, Valentina Lombardo, Giuseppe Angelico, Paolo Scollo, Giuseppe Scibilia, Alessandra Pizzo

      • Resumen

      págs. 746-756

      

    • Harnessing biomarkers to guide immunotherapy in esophageal cancer: toward precision oncology

      Amany I. Almars, Sameerah Shaheen, Nahlah M. Ghouth, Iman S. Abumansour, Asim Abdulaziz Khogeer, Fayez Alsulaimani, Ahmed M. Basri, Nasser A. Elhawary, Tabinda Hasan, Hailah M. Almohaimeed

      • Resumen

      págs. 757-776

      

    • Diagnostic and prognostic significance of circulating extracellular vesicles in gastrointestinal cancers

      Ankita Arora, Vinit Sharma, Anikait Kaushal, Anjali Aggarwal

      • Resumen

      págs. 777-788

      

    • Oligometastatic disease in pancreatic cancer: is there a role for curative-intent surgery? A narrative review

      César Pablo Ramírez Plaza, Marta Roldón Golet, Antonio Pérez Daga, Fernando Pereira Pérez

      • Resumen

      págs. 789-803

      

    • Application of artificial intelligence in oral potentially malignant disorders: current opinions and future barriers

      Guo Xuze, He Yaozu, Qi Han, Xie Jialin, Jia Yi, Li You, Wu Fanglong

      • Resumen

      págs. 804-817

      

    • Unraveling the role of specificity protein 1 in gliomas: pathophysiology and clinical implications

      Aida Naseri, Sepideh Razi, Nima Rezaei

      • Resumen

      págs. 818-840

      

    • Ultrahypofractionated radiotherapy in one or two sessions for localized prostate cancer: a review of the evidence and future perspectives

      Miguel Ángel Berenguer Francés, Abrahams Ocanto, Thomas Zilli, F. López Campos, Francisco Javier Celada Álvarez, A. Gómez-Iturriaga, Alison Tree, Stefano Arcangeli, Felipe Couñago Lorenzo

      • Resumen

      págs. 841-849

      

    • Cancer metabolism: bridging tumorigenesis mechanisms to treatment susceptibility

      Ji'an Liu, Dan Shan, Zhou Zhaokai, Xutao Wen, Rao Fu, Bo Xu, Luo Peng, Zhengrui Li, Ling Zhang

      • Resumen

      págs. 850-859

      

  • SPECIAL ARTICLE

    • Management of late toxicities and specific follow-up needs of adolescent and young adult cancer survivors: recommendations from scientific societies in Spain

      José Alejandro Pérez Fidalgo, Pilar Alonso, Maitane Andión Catalán, María Adela Cañete Nieto, Erica Collado, Carmen Garrido Colino, José Gómez Codina, Xavier Díaz Carrasco, Ramón García Sanz, Sergio Hernández Expósito, T. López Fernández, Gabriela Medín, A. Molinés Honrubia, Alberto Moreno Vega, Mónica Ramos, Íñigo San Miguel, Joaquín Sánchez García, F. Santolaya

      • Resumen

      págs. 860-879

      

    • SEOM-AEEMT consensus on occupational cancer and cancer-associated disability

      Laura Mezquita, Mª Teófila Vicente Herrero, Patricia Cruz, María Victoria Ramírez Iñiguez de la Torre, Julia Hidalgo Coloma, Luisa Capdevila García, Oscar Gallego Rubio, Aitana Calvo Ferrándiz, Katerine Martínez, Javier Perez Altozano, Raquel Molina Villaverde, Miguel García Pardo, Laura Gutiérrez Sainz, Elena Moreno Atahonero, Martín Oré Arce, César Serrano, María Jesús Terradillos García, María del Rosario Valero Muñoz, Luis Reinoso Barbero, César A. Rodríguez, Beatriz Calvo Cerrada

      • Resumen

      págs. 880-894

      

  • RESEARCH ARTICLE

    • Comparison of clinical characteristics and survival between HER2-zero and HER2-low in early breast cancer: a retrospective observational study

      Violeta Núñez Álvarez, Belén González Castilla, Belén Fernández Rivero, María Hernández Carrasco, Jaime Lluch Gómez, Irene Sánchez Lobón, María Ángeles Ocaña de la Rosa, Yulema Menguiano Romero, Eduardo Perdomo Zaldívar, Lourdes Rodríguez Pérez, Encarnación Benítez Rodríguez, José Manuel Baena Cañada

      • Resumen

      págs. 895-905

      

    • Long-term outcomes of accelerated partial breast irradiation with multicatheter interstitial brachytherapy versus whole breast irradiation: an 11-Year clinical practice follow-up study

      Sara Garduño Sánchez, María Isabel Villanego Beltrán, Juan Gómez Salgado, Javier Jaén Olasolo

      • Resumen

      págs. 906-916

      

    • Personalized recurrence risk prediction in early-stage breast cancer through an integrative mathematical model based on MammaPrint®, radiotherapy, phenotype, and clinicopathological factors

      J. Sánchez Mazón, Ana de Juan Ferré, José Manuel López Vega, Carlos López López

      • Resumen

      págs. 917-923

      

    • Investigation of the prevalence of HER2-ultralow and the effects of HER2 status (HER2-null vs. HER2-ultralow) on survival in HER2-negative early-stage breast cancer

      Alper Turkel, Sultan Çiğdem Irkkan, İlknur Deliktaş Onur, Cengiz Karacin

      • Resumen

      págs. 924-933

      

    • PARP inhibitors-associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group

      M. Sánchez Cánovas, Javier López Robles, Francisco José García Verdejo, Diego Cacho Lavín, Helena Oliveres, Alberto Garrido Fernández, Eva Coma, Teresa Quintanar, Carmen Salvador Coloma, David Fernández Garay, José David Cumplido Burón, Ana Isabel Ferrer Pérez, A. Carbó Bagué, Francisco Javier Teigell Muñoz, Rubén García López, Andrea Martínez Marín, Andrés Jesús Muñoz Martín

      • Resumen

      págs. 934-941

      

    • Lack of association between prior or concurrent malignancies and overall survival in gastroesophageal cancer: evidence from a large European single-center cohort

      Hannah C. Puhr, Luzia Berchtold, Linda Zingerle, Martin Korpan, Julia M. Berger, Gerd Jomrich, Reza Asari, Sebastian F. Schoppmann, Gerald W. Prager, Elisabeth S. Bergen, Anna S. Berghoff, Matthias Preusser, Aysegül Ilhan Mutlu

      • Resumen

      págs. 942-952

      

    • Integrative genomic analysis identifies clinically relevant prognostic markers for colorectal cancer patients with liver metastasis

      Li Wentao, Liu Ming, Wu Liula, Bosen Zhu, Li Xiangtao, Yang Ziyi, Yi Liang, Lin Junqiong

      • Resumen

      págs. 953-962

      

    • Efficacy and safety of cetuximab-based versus platinum-based chemoradiation in HNSCC: evidence from a meta-analysis of 10 randomized controlled trials

      Tarun Kumar, Nishu Kesh, Atindra Kumar Pandey, Ankita Chakrawal, Bhavana Singh, Pal Manjusha, Monika Rajput, Ruhi Dixit, Pai Esha, Manoj Pandey

      • Resumen

      págs. 963-973

      

    • Chemotherapy sensitivity of primary glioblastoma cells and immunohistochemical markers to predict of survival of patients with of glioblastoma

      Alexandr Chernov, Aleksei Chutko, Diana Alaverdian, Vadim Kashuro, Elvira Galimova

      • Resumen

      págs. 974-985

      

    • MRI-based deep learning radiomics in predicting histological differentiation of oropharyngeal cancer: a multicenter cohort study

      Pan Zhaoyu, Lu Wei, Yu Changyun, Fu Sen, Ling Hang, Liu Yong, Zhang Xin, Gong Liang

      • Resumen

      págs. 986-994

      

    • Diagnostic imaging modalities to detect regional nodal involvement in oral squamous cell carcinoma: a systematic review and meta-analysis

      Maria García Iruretagoyena, Alejandra Outeiriño Fernández, María Sobrido Prieto, Amaia Bilbao González, Alicia González Mourelle

      • Resumen

      págs. 995-1004

      

    • Diagnostic accuracy of next-generation sequencing (NGS) for identifying actionable mutations in advanced non-small cell lung cancer: Systematic Review and Meta-Analysis

      Nicolás Téllez Castillo, Ana M. Goyeneche García, Luisa M. Montoya Quesada, Óscar A. Gamboa Garay, Ricardo E. Bruges Maya

      • Resumen

      págs. 1005-1015

      

    • Safety and pharmacokinetics evaluation of oroxylin A in Chinese healthy volunteers: a phase I, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect study

      Yang Fan, Meng Xianmin, Qin Shukui, Guo Qinglong, Wei Libin, Zhao Di

      • Resumen

      págs. 1016-1029

      

    • Implementation of the precision oncology program in catalonia’s public health system: results, lessons learned, and future prospects

      Pilar Mur, Anna Pozuelo, Josep Tabernero Caturla, Joan Albanell Mestres, Beatriz Bellosillo Paricio, Francesc Bosch, Javier Briones Meijide, Joan Brunet i Vidal, D. Colomer, Montserrat Domenech Santasusana, Joan Manel Fontanet, Xavier Matías-Guiu Guía, Ramón Salazar Soler, Rosa María Vivanco Hidalgo, Meritxell Mollà Armadà, Lucas Moreno, Aleix Prat, Josép María Ribera Santasusana, Ramón Clèries Soler, A. Guarga Rojas, Josep Alfons Espinàs, Josep Maria Borràs Andrés

      • Resumen

      págs. 1030-1039

      

    • A topical nociceutical formulation ameliorates chemotherapy-induced peripheral neuropathy: a pilot randomized clinical study

      Sònia Servitja Tormo, María Castro Henriques, Iñaki Álvarez-Busto, Carlota Díez Franco, Alba Medina Castillo, María Asunción Algarra García, Elena López Miranda, Margaret Lario Martínez, María Isabel Luengo Alcázar, Miguel Borregón, Ana Davó, Anna Gasull Delgado, Sara Roque García, Ana Gonzaga López, Jesús Manuel Poveda Ferriols, Severine Pascal, Ana María Mitroi Marinescu, Marta García Escolano, Asia Ferrández, Clotilde Ferrándiz Huertas, Antonio Ferrer Montiel

      • Resumen

      págs. 1040-1048

      

    • Global regulatory variability in small-molecule inhibitor approvals: Differences in timelines, dosing, and pediatric indications across FDA, EMA, and PMDA

      Antía Gómez Fernández, Alba Rubio San Simón, Sae Ishimaru, Jen Hao Wu, C. Michel Zwaan, Alwin D.R. Huitema, Francisco Bautista

      • Resumen

      págs. 1049-1064

      

  • BRIEF RESEARCH ARTICLE

    • Biochemical landscape of breast cancer: integrating serum markers with clinical prognosis and staging

      Naif Abdullah R. Almalki, Mohammed Obaid Alharbi, Mirza Rafi Baig, Salma Naqvi, Fahad A. Al-Abbasi, Mohammed Usaid, Firoz Anwar

      • Resumen

      págs. 1065-1074

      

  • CORRESPONDENCE

    • The precision of a report on precision

      Vicente Valentí Moreno

      págs. 1075-1075

      

    • Response to the letter to the editor entitled “The precision of a report on precision”

      Pilar Mur, Anna Pozuelo, Josep Tabernero Caturla, Joan Albanell Mestres, Beatriz Bellosillo Paricio, Francesc Bosch, Javier Briones Meijide, Joan Brunet i Vidal, D. Colomer, Montserrat Domenech Santasusana, Joan Manel Fontanet, Xavier Matías-Guiu Guía, Ramón Salazar Soler, Rosa María Vivanco Hidalgo, Meritxell Mollà Armadà, Lucas Moreno, Aleix Prat, Josép María Ribera Santasusana, Ramón Clèries Soler, A. Guarga Rojas, Josep Alfons Espinàs, Josep Maria Borràs Andrés

      págs. 1076-1078